Insulet (PODD) EPS (Basic) Growth (5y) (2015 - 2026)
Insulet (PODD) EPS (Basic) Growth (5y) (2015 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.61 Bn | 194.01 Bn | 7.27 Bn |
| 2 | Stryker | 127.81 Bn | 124.34 Bn | 4.50 Bn |
| 3 | Medtronic | 119.04 Bn | 109.82 Bn | 6.41 Bn |
| 4 | Boston Scientific | 73.68 Bn | 73.14 Bn | 3.85 Bn |
| 5 | Edwards Lifesciences | 51.96 Bn | 47.71 Bn | 1.35 Bn |
| 6 | Dexcom | 34.36 Bn | 32.41 Bn | 830.00 Mn |
| 7 | GE HealthCare Technologies | 33.83 Bn | 31.72 Bn | 2.18 Bn |
| 8 | Koninklijke Philips | 26.36 Bn | 23.04 Bn | 4.55 Bn |
| 9 | Steris | 23.06 Bn | 22.58 Bn | 684.20 Mn |
| 10 | Insulet | 10.34 Bn | 9.81 Bn | 562.60 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 41.42% |
| Dec 31, 2025 | 49.52% |
| Sep 30, 2025 | 47.80% |
| Jun 30, 2025 | 7.40% |
| Mar 31, 2025 | 76.50% |
| Dec 31, 2024 | 77.09% |
| Sep 30, 2024 | 142.53% |
| Jun 30, 2024 | 158.34% |
| Mar 31, 2024 | 58.27% |
| Dec 31, 2023 | 54.53% |
| Sep 30, 2023 | 92.51% |
| Jun 30, 2023 | 73.27% |
| Mar 31, 2023 | 38.22% |
| Dec 31, 2021 | 273.44% |
| Sep 30, 2021 | 177.96% |
| Jun 30, 2021 | -169.48% |
| Dec 31, 2020 | -5.61% |
| Sep 30, 2020 | 66.12% |
| Jun 30, 2020 | 47.26% |
| Mar 31, 2020 | -6.27% |